← Back to events
ActiveBusiness

FDA Seeks Public Input to Support Ibogaine Research

What happened

The U.S. Food and Drug Administration today announced a request for information (RFI) describing approaches the agency is considering for the design of early-phase clinical trials of ibogaine drug products and seeking public input on those approaches.

Summary assembled by rule from the sources below

Why it's spreading

Sources